GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,891 Cr | ₹1,517 Cr | ₹1,559 Cr | ₹871 Cr | ₹1,075 Cr |
What is the latest Sundry Debtors ratio of GLAND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹1,891 Cr |
| Mar2025 | ₹1,517 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹871 Cr |
| Mar2022 | ₹1,075 Cr |
How is Sundry Debtors of GLAND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,891 Cr | 24.72 | |
| Mar2025 | ₹1,517 Cr | -2.70 | |
| Mar2024 | ₹1,559 Cr | 78.87 | |
| Mar2023 | ₹871 Cr | -18.93 | |
| Mar2022 | ₹1,075 Cr | - | |
Compare Sundry Debtors of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹49,949.6 Cr | -2% | 4% | 57.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2% |
4% |
57.8% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses